News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
616,281 Results
Type
Article (49475)
Company Profile (211)
Press Release (566595)
Section
Business (170887)
Career Advice (1996)
Deals (30315)
Drug Delivery (98)
Drug Development (75351)
Employer Resources (149)
FDA (16227)
Job Trends (13652)
News (299502)
Policy (29799)
Tag
Academia (2705)
Alliances (44701)
Alzheimer's disease (1235)
Approvals (16183)
Artificial intelligence (158)
Bankruptcy (256)
Best Places to Work (10964)
Biotechnology (141)
Breast cancer (184)
Cancer (1395)
Cardiovascular disease (115)
Career advice (1674)
Cell therapy (286)
Clinical research (60516)
Collaboration (473)
Compensation (172)
COVID-19 (2594)
C-suite (106)
Data (1365)
Diabetes (167)
Diagnostics (5824)
Earnings (62950)
Employer resources (135)
Events (87860)
Executive appointments (370)
FDA (16928)
Funding (419)
Gene therapy (194)
GLP-1 (617)
Government (4384)
Healthcare (18479)
Infectious disease (2683)
Inflammatory bowel disease (120)
Interviews (328)
IPO (13917)
Job creations (3095)
Job search strategy (1437)
Layoffs (361)
Legal (6198)
Lung cancer (211)
Lymphoma (100)
Manufacturing (199)
Medical device (14117)
Medtech (14121)
Mergers & acquisitions (16589)
Metabolic disorders (468)
Neuroscience (1558)
NextGen Class of 2024 (6521)
Non-profit (4484)
Northern California (1517)
Obesity (270)
Opinion (220)
Patents (109)
People (50323)
Phase I (18309)
Phase II (26764)
Phase III (20429)
Pipeline (500)
Postmarket research (2378)
Preclinical (7421)
Radiopharmaceuticals (259)
Rare diseases (278)
Real estate (5101)
Regulatory (20687)
Research institute (2428)
Resumes & cover letters (316)
Southern California (1316)
Startups (3659)
United States (13909)
Vaccines (588)
Weight loss (204)
Date
Today (3)
Last 7 days (327)
Last 30 days (2102)
Last 365 days (32957)
2024 (32852)
2023 (37479)
2022 (48284)
2021 (52257)
2020 (51143)
2019 (44966)
2018 (34181)
2017 (31036)
2016 (30044)
2015 (34811)
2014 (26682)
2013 (22281)
2012 (23937)
2011 (24526)
2010 (22490)
Location
Africa (781)
Arizona (171)
Asia (37155)
Australia (6359)
California (3405)
Canada (1309)
China (304)
Colorado (158)
Connecticut (169)
Europe (83001)
Florida (520)
Georgia (120)
Illinois (392)
Indiana (221)
Maryland (616)
Massachusetts (2646)
Michigan (157)
Minnesota (246)
New Jersey (1026)
New York (992)
North Carolina (717)
Northern California (1517)
Ohio (136)
Pennsylvania (834)
South America (1078)
Southern California (1316)
Texas (514)
Utah (100)
Washington State (352)
616,281 Results for "ra medical systems".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SetPoint Medical Announces Late-Breaking Data from RESET-RA Study at ACR Convergence 2024
November 18, 2024
·
5 min read
Drug Development
Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise
Erasca, Inc. announced it has entered into exclusive license agreements for two preclinical RAS programs—a potential best-in-class pan-RAS molecular glue and a potential first-in-class pan-KRAS inhibitor —and provided a pipeline update.
May 16, 2024
·
10 min read
Press Releases
Revolution Medicines Provides Clinical Updates from its RAS(ON) Inhibitor Portfolio
December 3, 2024
·
13 min read
Business
Ra Medical Systems Announces First Quarter 2023 Results
Ra Medical Systems, Inc. announced financial and company highlights for the first quarter ended March 31,2023.
June 2, 2023
·
12 min read
Press Releases
Erasca Announces Strong Momentum for Naporafenib and RAS Targeting Franchise
October 25, 2024
·
10 min read
Press Releases
Revolution Medicines to Host RAS(ON) Inhibitor Clinical Update Webcast on December 2, 2024
November 28, 2024
·
1 min read
Press Releases
CORXEL Acquires Worldwide (excluding Greater China) Rights to an Oral Small Molecule GLP-1 RA for the Treatment of Obesity and Diabetes
December 23, 2024
·
3 min read
Press Releases
Cardiff Oncology Announces Positive Initial Data from First-line RAS-mutated mCRC Clinical Trial
December 10, 2024
·
7 min read
Press Releases
Aqtual Presents New Data on Development of RA Therapy Selection Test at ACR Convergence 2024
November 18, 2024
·
3 min read
Drug Development
Celon Pharma Announces Results of Phase II clinical trial for CPL’ 116, a JAK/ROCK dual inhibitor in the treatment of Rheumatoid Arthritis (RA)
Celon Pharma S.A. (CLN.WA) today announced the successful completion of a Phase 2 trial a JAK/ROCK dual inhibitor in the treatment of Rheumatoid Arthritis (RA).
June 17, 2024
·
7 min read
1 of 61,629
Next
